Crossmark

Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells

Crossref DOI link: https://doi.org/10.1007/s10565-022-09756-8

Published Online: 2022-09-07

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhan, Yujuan

Chen, Qiugu

Song, Yue

Wei, Xianli

Zhao, Tingxiu

Chen, Bonan

Li, Chengxi

Zhang, Wenbo

Jiang, Yanjun

Tan, Yuhui

Du, Biaoyan

Xiao, Jianyong

Wang, Kun
License Information

Text and Data Mining valid from 2022-09-07

Version of Record valid from 2022-09-07
More Information

Article History

Received: 9 January 2022

Accepted: 26 August 2022

First Online: 7 September 2022

Declarations

:

: The animal experiment was approved by the Institutional Animal Care and Use Committee at Guangzhou University of Chinese Medicine (Project No. 20190927002).

: Not applicable.

: Not applicable.

: The authors declare that there are no conflicts of interest.

Document is current

Any future updates will be listed below